ABOS
Price
$1.12
Change
-$0.09 (-7.44%)
Updated
Jun 27 closing price
Capitalization
69.36M
50 days until earnings call
GLSI
Price
$8.93
Change
-$0.00 (-0.00%)
Updated
Jun 27 closing price
Capitalization
120.18M
43 days until earnings call
Interact to see
Advertisement

ABOS vs GLSI

Header iconABOS vs GLSI Comparison
Open Charts ABOS vs GLSIBanner chart's image
Acumen Pharmaceuticals
Price$1.12
Change-$0.09 (-7.44%)
Volume$5.68M
Capitalization69.36M
Greenwich LifeSciences
Price$8.93
Change-$0.00 (-0.00%)
Volume$337
Capitalization120.18M
ABOS vs GLSI Comparison Chart in %
Loading...
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ABOS vs. GLSI commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ABOS is a Hold and GLSI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ABOS: $1.12 vs. GLSI: $8.93)
Brand notoriety: ABOS and GLSI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ABOS: 1624% vs. GLSI: 1%
Market capitalization -- ABOS: $69.36M vs. GLSI: $120.05M
ABOS [@Biotechnology] is valued at $69.36M. GLSI’s [@Biotechnology] market capitalization is $120.05M. The market cap for tickers in the [@Biotechnology] industry ranges from $299.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.3B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ABOS’s FA Score shows that 0 FA rating(s) are green whileGLSI’s FA Score has 0 green FA rating(s).

  • ABOS’s FA Score: 0 green, 5 red.
  • GLSI’s FA Score: 0 green, 5 red.
According to our system of comparison, ABOS is a better buy in the long-term than GLSI.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ABOS’s TA Score shows that 4 TA indicator(s) are bullish while GLSI’s TA Score has 2 bullish TA indicator(s).

  • ABOS’s TA Score: 4 bullish, 6 bearish.
  • GLSI’s TA Score: 2 bullish, 6 bearish.
According to our system of comparison, ABOS is a better buy in the short-term than GLSI.

Price Growth

ABOS (@Biotechnology) experienced а -6.67% price change this week, while GLSI (@Biotechnology) price change was +0.11% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ABOS is expected to report earnings on Aug 18, 2025.

GLSI is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
GLSI($120M) has a higher market cap than ABOS($69.4M). GLSI YTD gains are higher at: -20.481 vs. ABOS (-34.884). GLSI has higher annual earnings (EBITDA): -16.75M vs. ABOS (-111.98M). ABOS has more cash in the bank: 149M vs. GLSI (2.75M). ABOS (0) and GLSI (0) have equivalent revenues.
ABOSGLSIABOS / GLSI
Capitalization69.4M120M58%
EBITDA-111.98M-16.75M668%
Gain YTD-34.884-20.481170%
P/E RatioN/AN/A-
Revenue00-
Total Cash149M2.75M5,418%
Total Debt29MN/A-
TECHNICAL ANALYSIS
Technical Analysis
ABOSGLSI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
84%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
90%
Bullish Trend 3 days ago
86%
Momentum
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
MACD
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
84%
TrendWeek
ODDS (%)
Bearish Trend 3 days ago
89%
Bullish Trend 3 days ago
81%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
86%
Advances
ODDS (%)
Bullish Trend 13 days ago
77%
N/A
Declines
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 4 days ago
86%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
N/A
Aroon
ODDS (%)
Bullish Trend 3 days ago
71%
Bearish Trend 3 days ago
89%
View a ticker or compare two or three
Interact to see
Advertisement
ABOS
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
GLSI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HWAUF0.200.01
+6.42%
Headwater Gold Inc.
NDEKF18.30N/A
N/A
Nitto Denko Corp.
APPEF0.68N/A
N/A
Appen Ltd.
PPAAY5.12N/A
N/A
PT Perusahaan Gas Negara Persaro
DRSLF3.18N/A
N/A
DORSEL HLDGS LTD.

ABOS and

Correlation & Price change

A.I.dvisor indicates that over the last year, ABOS has been loosely correlated with FHTX. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if ABOS jumps, then FHTX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ABOS
1D Price
Change %
ABOS100%
-7.44%
FHTX - ABOS
54%
Loosely correlated
-0.41%
CRBU - ABOS
53%
Loosely correlated
-5.19%
BEAM - ABOS
50%
Loosely correlated
-1.98%
IPSC - ABOS
49%
Loosely correlated
-5.74%
CRSP - ABOS
49%
Loosely correlated
N/A
More

GLSI and

Correlation & Price change

A.I.dvisor indicates that over the last year, GLSI has been loosely correlated with ABOS. These tickers have moved in lockstep 48% of the time. This A.I.-generated data suggests there is some statistical probability that if GLSI jumps, then ABOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To GLSI
1D Price
Change %
GLSI100%
N/A
ABOS - GLSI
48%
Loosely correlated
-7.44%
DNLI - GLSI
45%
Loosely correlated
-2.69%
IMNM - GLSI
44%
Loosely correlated
-0.23%
CLDX - GLSI
43%
Loosely correlated
-4.16%
CRSP - GLSI
42%
Loosely correlated
N/A
More